KURE Holdings — KraneShares MSCI All China Health Care Index ETF
All 52 reported holdings of KraneShares MSCI All China Health Care Index ETF (KURE) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Innovent Biologics, Inc. | 8.69% | $6.98M |
| BeOne Medicines AG | 8.17% | $6.57M |
| Wuxi Biologics (cayman) Inc. | 6.63% | $5.33M |
| Akeso Inc | 5.74% | $4.62M |
| WuXi AppTec Co., Ltd. | 5.68% | $4.57M |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.58% | $3.69M |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.29% | $3.45M |
| Sino Biopharmaceutical Limited | 4.18% | $3.36M |
| Cspc Pharmaceutical Group Limited | 3.61% | $2.90M |
| Hansoh Pharmaceutical Group Company Limited | 3.59% | $2.89M |
| WuXi AppTec Co., Ltd. | 3.12% | $2.51M |
| 3SBio Inc. | 2.88% | $2.31M |
| Yunnan Baiyao Group Co., Ltd. | 2.21% | $1.78M |
| Shanghai United Imaging Healthcare Co., Ltd. | 2.16% | $1.74M |
| Aier Eye Hospital Group Co., Ltd. | 2.01% | $1.62M |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. | 1.99% | $1.60M |
| Sinopharm Group Co. Ltd. | 1.85% | $1.49M |
| Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | 1.56% | $1.26M |
| Invesco Government & Agency Portfolio | 1.55% | $1.25M |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 1.54% | $1.24M |
| Huadong Medicine Co., Ltd. | 1.41% | $1.13M |
| WuXi XDC Cayman Inc | 1.33% | $1.07M |
| RemeGen Co Ltd | 1.23% | $989.75K |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 1.21% | $976.48K |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.20% | $966.73K |
| Haisco Pharmaceutical Group Co., Ltd. | 1.16% | $932.08K |
| XtalPi Holdings Limited | 1.06% | $853.86K |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1.05% | $845.93K |
| Shanghai Pharmaceuticals Holding Co., Ltd. | 1.04% | $835.90K |
| Shanghai Allist Pharmaceuticals Co Ltd | 0.99% | $794.36K |
| Beijing Wantai Biological Pharmacy Enterprise Co Ltd | 0.96% | $769.15K |
| Pharmaron Beijing Co., Ltd. | 0.94% | $757.06K |
| Genscript Biotech Corp | 0.90% | $720.67K |
| Shenzhen New Industries Biomedical Engineering Co Ltd | 0.87% | $701.23K |
| Shanghai RAAS Blood Products Co., Ltd. | 0.87% | $698.59K |
| Beijing Tong Ren Tang Co., Ltd. | 0.87% | $696.20K |
| Chongqing Zhifei Biological Products Co., Ltd. | 0.82% | $660.57K |
| APT Medical Inc | 0.82% | $657.05K |
| Imeik Technology Development Co Ltd | 0.81% | $650.81K |
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 0.79% | $636.16K |
| Changchun High-Tech Industry (group) Co., Ltd. | 0.78% | $625.47K |
| Hebei Changshan Biochemical Pharmaceutical Co Ltd | 0.76% | $612.65K |
| CSPC Innovation Pharmaceutical Co Ltd | 0.73% | $588.40K |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | 0.72% | $583.03K |
| Legend Biotech Corp | 0.71% | $570.52K |
| Shandong Weigao Group Medical Polymer Co.,ltd | 0.64% | $515.42K |
| Hangzhou Tigermed Consulting Co., Ltd | 0.45% | $364.36K |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. | 0.09% | $74.38K |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 0.07% | $52.44K |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 0.06% | $47.94K |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 0.05% | $43.19K |
| Shanghai Pharmaceuticals Holding Co., Ltd. | 0.03% | $27.65K |
KURE overview: performance, fees, allocation and SEC filings